TinyGemsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Poised to Potentially Change History
Jan 9, 2023
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical innovator, is enrolling patients in the United States and Europe for its potentially pivotal global clinical trial in humans for its lead drug candidate designed to treat glioblastoma multiforme (“GBM”), a common and one of the most aggressive primary brain cancers. “The drug, Berubicin, is an anthracycline chemotherapy agent that apparently has the unique ability to cross the blood-brain barrier to target tumors directly. The inability of anthracyclines to cross the blood-brain barrier has been identified as a major obstacle in treating aggressive brain tumors such as GBM and creates an opportunity for CNS Pharmaceuticals,” a recent article reads. “Anthracyclines are designed to damage the DNA in cancer cells,” CEO John Climaco is quoted as saying. “Anthracyclines as a class of chemotherapy have been used for over 60 years to treat a variety of cancers, including breast, ovarian, lung, lymphoma and leukemia, and other malignancies as well. However, historically, anthracyclines have never been used to treat primary or metastatic brain cancers because scientists could not demonstrate that anthracyclines were able to cross the blood-brain barrier and achieve significant levels of activity in the brain. Berubicin may change that history.”
To view the full article, visit https://ibn.fm/ZoGTt
About CNS Pharmaceuticals Inc.
CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company’s lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. For more information, visit the company’s website at www.CNSPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP
About TinyGems
TinyGems is your guide to the best and brightest in the under-appreciated small-cap sector. As one of 50+ brands within the InvestorBrandNetwork (“IBN”), TinyGems provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to reach millions of social media followers; and (5) a full array of corporate communications solutions. It’s time to uncover some of the best-kept secrets on Wall Street. TinyGems features innovative small-cap companies with huge potential, putting a spotlight on the best and brightest of these disruptors that have the technology, the talent, the drive, and the business models to make a huge impact in the markets and in portfolios. Whether it’s a game changing technology, a new more profitable product or service, or a star in a hot sector, TinyGems is the go-to source for actionable intelligence.
To receive SMS text alerts from TinyGems, text “Gems” to 844-397-5787 (U.S. Mobile Phones Only)
For more information, please visit https://www.TinyGems.com
Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer
TinyGems
Los Angeles, California
www.TinyGems.com
310.299.1717 Office
[email protected]
TinyGems is part of the InvestorBrandNetwork.
Yasmien Kurdi reveals she developed hives due to stress following daughter's alleged bullying
Yasmien Kurdi revealed that she developed hives due to the stress of dealing with the trauma suffered by her daughter Ayesha, who was allegedly bullied in school two years ago.
WATCH: BINI Mikha stars in Inigo Pascual’s music video for new single
Inigo Pascual unveiled his new single, “Pagdating ng Panahon,” with BINI Mikha Lim featuring in the music video that was partly directed by his dad, Piolo Pascual. The singer-songwriter-actor turned 29 last September 14, and said his new single was sort of his birthday gift, following the success of his last single, “Ikaw at Ikaw,”
Who is private prosecutor Erwin Matib?
On Day 27 of Vice President Sara Duterte"s impeachment trial, private prosecutor Erwin Matib led the direct examination of a Securities and Exchange Commission (SEC) witness.
Join #MoveCebu 2026 public forum, workshops for a liveable city
Rappler’s civic engagement arm MovePH is returning to Cebu for #MoveCebu: Sugbo alang sa Sugboanons, a three-day civic empowerment roadshow set for October 14 to 16, 2026
Saclag gets golden shot, Alvarez bags bronze as MMA fighters shine in Asian Games
Jean Claude Saclag advances to the final as he earns a chance to either match or surpass the silver medal he won in wushu in the 2014 edition, while Carlos Alvarez secures a bronze despite falling in the semifinals
WATCH: Sara Duterte impeachment trial | Sept. 21, 2026
MANILA, Philippines – Corporate and government procurement records are set to take center stage on Monday, Day 27 of Vice President Sara Duterte’s impeachment trial. The House prosecutors are expected to present witnesses from the Civil Service Commission, Securities and Exchange Commission and Philippine Government Electronic Procurement System to examine Duterte’s declared business interests and
LIVE UPDATES: Impeachment trial of Vice President Sara Duterte
Bookmark this page for Rappler's comprehensive coverage of Vice President Sara Duterte's impeachment trial at the Senate
Before ASEAN gold, Baguio spent 60 years fighting smoke
In its long history of tobacco control, Baguio City has treated tobacco use as the public health issue that it is, and not merely as an enforcement issue
Angara: PH schools focused on academics, unprepared for shootings
Education Secretary Juan Edgardo "Sonny" Angara said the country's schools need stronger security, adding that the agency has focused on the academic performance of Filipino learners. Angara said that the agency planned to roll out enhanced safety measures following the third case of deadly school shootings since June. “'Yong security measures, talaga kailangang paigtingin dahil hindi talaga kami handa sa mga ganitong shootings eh. Na-concentrate tayo sa academic performance ng mga bata,” Angara said.
Chinese President Xi Jinping will pay state visit to US this week, Beijing confirms
Chinese President Xi Jinping will pay a state visit to the United States from Wednesday to Friday, Beijing’s foreign ministry has confirmed. In an official statement on Monday, the ministry said Xi would visit the US from September 23 to 25. The trip – Xi’s first state visit since 2015 – will also mark his second face-to-face meeting this year with US President Donald Trump, as the world’s top two economies seek to stabilise a relationship tested by trade, technology and national security...
Sara Duterte Trial Day 27: SEC exec to verify her business interests
[Updated as of 10:08 a.m., Sept. 21, 2026] MANILA, Philippines — As the impeachment court continues to tackle Vice President Sara Duterte’s unexplained wealth on Monday, a Securities and Exchange Commission (SEC) official will testify on Duterte’s supposed business interests. SEC Company Registration and Monitoring Department Director Gerardo del Rosario is expected to authenticate the
10 Filipino Artists Reimagine Democracy Across Philippine Islands through “Sprints”
What does democracy look like when artists stop illustrating it as it is and start reimagining it as it could
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.